|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00304408 |
|
Date of registration:
|
16/03/2006 |
|
Primary sponsor: |
|
|
Public title:
|
Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody
|
|
Scientific title:
|
Association Between Clinical Response of Clostridium Difficile Colitis to Treatment and Emergence of Anti-C.Difficile Toxin Antibody |
|
Date of first enrolment:
|
January 2005 |
|
Target sample size:
|
10 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00304408 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Daniel M Musher, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Houston VA Medical Center |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- All patients at the Houston VA with documented C. difficile infection
Exclusion Criteria:
- None
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Antibiotic-Associated Colitis
|
|
Clostridium Enterocolitis
|
|
Pseudomembranous Colitis
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|